glp-1 addiction trials medications get at the heart of addiction: study – WashU Medicine GLP-1 Analogues in the Neurobiology
Description
In the SURPASS-2 head-to-head against semaglutide for diabetes, tirzepatide produced significantly greater A1c reductions
Ongoing risk-benefit assessment is essential
Theres a lot to be excited about in the age of GLP-1s
If you're also on other diabetes medications, check in with your clinician
If you meet the eligibility criteria, explore this option and work closely with your healthcare provider throughout the application process
The trajectory is clear
